The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMedium•7 May 2026•

1 min read

US Mid-Cap Stocks Miss Q1 Earnings Estimates Amid Biotech and Crypto Struggles

Key Facts

1Coinbase Global reported a quarterly loss of $0.17 per share, missing the consensus estimate of $0.36 earnings per share.

2Celldex Therapeutics reported a loss of $1.18 per share, wider than the estimated loss of $1.10.

Version History

1 additional source confirmed this story

A series of Q1 earnings reports for US mid-cap companies revealed significant misses against analyst expectations across several key sectors. Coinbase Global reported a quarterly loss of $0.17 per share, failing to meet the consensus estimate of $0.36 in earnings. In the renewable energy space, Clearway Energy posted a loss of $1.35 per share, which was substantially wider than the anticipated $0.45 loss. The biotech sector also faced headwinds, with Celldex Therapeutics reporting a loss of $1.18 per share, exceeding the estimated loss of $1.10. These results highlight the ongoing operational challenges within the crypto, energy, and biotech industries. Consequently, the broad earnings miss is expected to exert downward pressure on the impacted equities in the short term.